BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38203290)

  • 21. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
    Pouyanrad S; Rahgozar S; Ghodousi ES
    Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia.
    Jiang Q; Lu X; Huang P; Gao C; Zhao X; Xing T; Li G; Bao S; Zheng H
    Biomed Res Int; 2018; 2018():5724686. PubMed ID: 29967774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.
    Umerez M; Garcia-Obregon S; Martin-Guerrero I; Astigarraga I; Gutierrez-Camino A; Garcia-Orad A
    Pharmacogenomics; 2018 Mar; 19(4):361-373. PubMed ID: 29469670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
    Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
    J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
    Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
    J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
    Mei Y; Gao C; Wang K; Cui L; Li W; Zhao X; Liu F; Wu M; Deng G; Ding W; Jia H; Li Z
    Cancer Sci; 2014 Apr; 105(4):463-72. PubMed ID: 24720529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
    Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
    Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
    Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
    Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
    Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia.
    Iparraguirre L; Gutierrez-Camino A; Umerez M; Martin-Guerrero I; Astigarraga I; Navajas A; Sastre A; Garcia de Andoin N; Garcia-Orad A
    Pharmacogenet Genomics; 2016 Nov; 26(11):517-525. PubMed ID: 27649261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
    Rashed WM; Hammad AM; Saad AM; Shohdy KS
    Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
    Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
    Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
    Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NET1 Enhances Proliferation and Chemoresistance in Acute Lymphoblastic Leukemia Cells.
    Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
    Oncol Res; 2019 Aug; 27(8):935-944. PubMed ID: 31046876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia.
    Zhang H; Luo XQ; Zhang P; Huang LB; Zheng YS; Wu J; Zhou H; Qu LH; Xu L; Chen YQ
    PLoS One; 2009 Nov; 4(11):e7826. PubMed ID: 19915715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p/NET1 axis.
    Yang X; Li Y; Zhang Y; Liu J
    Hematology; 2022 Dec; 27(1):11-22. PubMed ID: 34957935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsa-miR-196a2 polymorphism increases the risk of acute lymphoblastic leukemia in Chinese children.
    Tong N; Xu B; Shi D; Du M; Li X; Sheng X; Wang M; Chu H; Fang Y; Li J; Wu D; Zhang Z
    Mutat Res; 2014 Jan; 759():16-21. PubMed ID: 24291415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Expression Profiling of Acute Lymphoblastic Leukemia in Children with Very Early Relapse.
    Núñez-Enríquez JC; Bárcenas-López DA; Hidalgo-Miranda A; Jiménez-Hernández E; Bekker-Méndez VC; Flores-Lujano J; Solis-Labastida KA; Martínez-Morales GB; Sánchez-Muñoz F; Espinoza-Hernández LE; Velázquez-Aviña MM; Merino-Pasaye LE; García Velázquez AJ; Pérez-Saldívar ML; Mojica-Espinoza R; Ramírez-Bello J; Jiménez-Morales S; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):644-655. PubMed ID: 28476192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
    Jiang J; Liu Y; Zhao Y; Tian F; Wang G
    Technol Cancer Res Treat; 2019; 18():1533033819852990. PubMed ID: 31138034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia].
    Zeng MN; Ma WL; Zheng WL
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):585-90. PubMed ID: 27535859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.